Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

MYO

SellHot Air

Myomo, Inc. · Healthcare · United States · $63M · Avg Vol: $916K/d

34
StockRank
Get insider-trade alerts
Q
31
V
29
M
65
P/E (TTM)
ROE
-123.8%
D/E
3.4x
Dividend %

COMPANY DESCRIPTION

Myomo, Inc. is a medical robotics company that develops and markets wearable orthotic devices for individuals with neuromuscular conditions. The company is a niche leader in the non-invasive robotic bracing market, providing proprietary myoelectric technology to restore movement in paralyzed or weakened upper limbs.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue15.6M19.2M32.6M40.9M38.1%43.3M45.6M51.2M11.9%
EPS-0.30-0.28-0.16-0.37-0.34-0.31-0.22
Shares39.6M27.1M34.4M38.5M-2.9%39.6M
Debt0.6M0.6M8.1M19.4M227.1%20.1M
Equity6.4M9.0M24.7M11.4M21.5%
Op CF-10.2M-6.2M-3.3M-14.5M-7.1M
Inv CF-0.3M-2.0M0.3M-7.1M
Fin CF0.4M9.7M20.9M11.4M
Loading 1Y...
PRICE (1Y)+47.3%
0.931.161.401.631.86Jul 29Aug 19Sep 9
SMA 50SMA 200

Close
$1.37
RSI (14)
29.1
52W High
$1.88
From 52W High
0.7%

SCORE BREAKDOWN

Quality
31
ROIC
-43.3%18.4
ROE
-123.8%7.2
GP/Assets
76.5%95.4
Op. Margin
-19.3%25.2
FCF/Assets
-23.5%18.0
Piotroski
316.1
Int. Cover
-32.4x14.5
D/E Ratio
3.44x2.9
Current Ratio
2.31x44.7
Value
29
P/E (TTM)
N/A
EV/EBITDA
-6.1x25.0
P/FCF
N/A
P/B
9.8x12.3
P/S
1.3x78.7
Div Yield
N/A
Momentum
65
52W High %
73%54.2
RS 6M
89%96.2
SMA 50/200
1.27x92.1
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+35%45.2
Q Growth
N/A

FUNDAMENTALS

Market Cap
$63M
P/E (Forward)
-6.5x
Gross Margin
68.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MYO are excluded.

TickerCompanyMkt CapStockRankSignal
MYOMyomo, Inc.(you)$63M34Sell
ECORelectroCore, Inc.$87M32Sell
OMOutset Medical, Inc.$74M24Sell
SRTSSensus Healthcare, Inc.$58M22Sell
XTNTXtant Medical Holdings, Inc.$54M44Hold
LUNGPulmonx Corporation$102M29Sell
MXCTMaxCyte, Inc.$126M32Sell
SNWVSANUWAVE Health, Inc.$51M47Hold
ARAYAccuray Incorporated$53M19Strong Sell
LNSRLENSAR, Inc.$102M22Sell

Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%

Myomo, Inc. (MYO): Stock Score Summary

Myomo, Inc. (MYO) has a MoatMap StockRank of 34/100 based on Quality (31/100), Value (29/100), and Momentum (65/100) factor scores. The current signal is SELL.

Myomo, Inc. is a medical robotics company that develops and markets wearable orthotic devices for individuals with neuromuscular conditions. The company is a niche leader in the non-invasive robotic bracing market, providing proprietary myoelectric technology to restore movement in paralyzed or weakened upper limbs.

Key Financial Metrics

Price$1.37
Market Cap$63M
P/E (Forward)-6.55
Price/Book9.80
Return on Equity-123.8%
Return on Invested Capital-43.3%
Debt/Equity3.44x
Gross Margin68.4%
Operating Margin-19.3%
Revenue Growth21.3%
Free Cash Flow$-9M

Myomo, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Myomo, Inc.’s (MYO) StockRank?
MoatMap’s StockRank for Myomo, Inc. (MYO) is 34/100, with a Sell signal. It is a composite of Quality (31), Value (29), and Momentum (65) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Myomo, Inc. have an economic moat?
Myomo, Inc. (MYO) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Myomo, Inc. a buy, hold, or sell?
MoatMap’s current signal for Myomo, Inc. (MYO) is Sell, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Myomo, Inc. in?
Myomo, Inc. (MYO) operates in the Healthcare sector, specifically the Medical Devices industry (United States).